Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) Depreciation & Amortization - Total (2018 - 2025)

Option Care Health (OPCH) has disclosed Depreciation & Amortization - Total for 8 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization - Total rose 24.5% year-over-year to $11.0 million, compared with a TTM value of $33.8 million through Dec 2025, up 16.03%, and an annual FY2025 reading of $33.8 million, up 16.03% over the prior year.
  • Depreciation & Amortization - Total was $11.0 million for Q4 2025 at Option Care Health, up from $7.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $11.0 million in Q4 2025 and bottomed at $6.6 million in Q3 2024.
  • Average Depreciation & Amortization - Total over 5 years is $7.9 million, with a median of $7.7 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization - Total plummeted 31.28% in 2021, then grew 24.5% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $8.5 million in 2021, then decreased by 15.47% to $7.2 million in 2022, then fell by 0.87% to $7.1 million in 2023, then grew by 24.13% to $8.9 million in 2024, then rose by 24.5% to $11.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for OPCH at $11.0 million in Q4 2025, $7.8 million in Q3 2025, and $7.7 million in Q2 2025.